No Data
No Data
List of converted stocks (Part 2) [List of converted stocks for Parabolic Signal]
○ List of symbols for sell conversion in the market Code Company Name Closing Price SAR Main Board <1301> Kyokuyo 3940 4045 <1860> Todabuild 9801026 <187A> Samty HD 32903300 <1939> Yondenko 14761576 <1942> Kandenko 22222349 <1944> Kinden 30713263 <2002> Nisshin Flour G 18281856 <2410> Carrier
List of cloud-clearing stocks (weekly) (part 2)
○ Cloud Breakthrough Stocks List Market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo Main Board <8334> Gunma Silver 967 904.5 780.5<8343> Akita Silver 2120 2089.75 1954.5<8388> Awa Silver 2700 2655 2459<8418> Yamaguchi FG 1626 1600.5 1376<8439> Tokyo Century 1602 1552.25 14
Companies like Kachitas, TechnoPro HD, etc. (additional) Rating
Downgrade - Bearish code stock name securities firm conventional changes after ------------------------------------------------- <6301> Komatsu Yamato "2" "3" <6305> Hitachi Construction Machinery Yamato "2" "3" Target stock price change code stock name securities firm conventional changes after ------------------------------------------------- <6028> TechnoPro HDSMBC Nikko 3200 yen 3
Tokyotokeiba Co., Ltd. Reports Strong Growth and Increased Dividends
Tokyotokeiba: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (consolidated) (completion of mid-term review by certified public accountants, etc.)
Canon Inc-spons adr, 3Q operating profit increased by 14.4% to 296.6 billion yen.
Canon Inc-spons adr <7751> announced its third quarter financial results for the fiscal year ending December 2024, with revenue increasing by 7.3% year-on-year to 3 trillion 236.1 billion 11 million yen, and operating profit increasing by 14.4% to 296.6 billion 38 million yen. The gross profit margin increased to 47.8%, surpassing the same period last year by 0.8 points, due to cost reductions and improvements in product mix, with gross profit also increasing by 7.1% year-on-year to 516.4 billion yen. Positive evaluation for Takeda Pharmaceutical Co., Ltd. <4502> in the mid-term and Sony Corporation <7735>.